Review Article| Volume 55, P131-145, September 2021

The Role of Node Dissection for Thyroid Cancer

      Regional lymph node metastases are common in patients with thyroid cancer.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Advances in Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Lim H.
        • Devesa S.S.
        • Sosa J.A.
        • et al.
        Trends in thyroid cancer incidence and mortality in the United States, 1974-2013.
        JAMA. 2017; 317: 1338-1348
        • Siegel R.L.
        • Miller K.D.
        • Jemal A.
        Cancer statistics, 2020.
        CA Cancer J Clin. 2020; 70: 7-30
        • Randle R.W.
        • Rosen J.E.
        Thyroid cancer mortality in an aging population.
        Bull Am Coll Surg. 2019; 104: 37-40
        • Stulak J.M.
        • Grant C.S.
        • Farley D.R.
        • et al.
        Value of preoperative ultrasonography in the surgical management of initial and reoperative papillary thyroid cancer.
        Arch Surg. 2006; 141 ([discussion 494-6]): 489-494
        • Randle R.W.
        • Balentine C.J.
        • Leverson G.E.
        • et al.
        Trends in the presentation, treatment, and survival of patients with medullary thyroid cancer over the past 30 years.
        Surgery. 2017; 161: 137-146
        • Kloos R.T.
        • Eng C.
        • et al.
        • American Thyroid Association Guidelines Task Force
        Medullary thyroid cancer: management guidelines of the American Thyroid Association.
        Thyroid. 2009; 19: 565-612
      1. Ghanem M, Olson MT, Zeiger MA. Approach to thyroid nodules. In: Textbook of Endocrine Surgery: 3rd edition. In: Clark OH, Duh QY, Kebebew E, Gosnell JE, Shen WT, editors. Jaypee Brothers Medical Publishers; 2016. p. 121–30.

        • Schmid D.
        • Ricci C.
        • Behrens G.
        • et al.
        Adiposity and risk of thyroid cancer: a systematic review and meta-analysis.
        Obes Rev. 2015; 16: 1042-1054
        • Bates M.F.
        • Lamas M.R.
        • Randle R.W.
        • et al.
        Back so soon? Is early recurrence of papillary thyroid cancer really just persistent disease?.
        Surgery. 2018; 163: 118-123
        • Kim H.K.
        • Ha E.J.
        • Han M.
        • et al.
        Reoperations for structurally persistent or recurrent disease after thyroidectomy.
        Sci Rep. 2020; 10: 12376
        • McDow A.D.
        • Shumway C.M.
        • Pitt S.C.
        • et al.
        Utility of early postoperative unstimulated thyroglobulin in influencing decision making in patients with papillary thyroid carcinoma.
        Ann Surg Oncol. 2019; 26: 4002-4007
        • Randle R.W.
        • Bates M.F.
        • Schneider D.F.
        • et al.
        Survival in patients with medullary thyroid cancer after less than the recommended initial operation.
        J Surg Oncol. 2018; 117: 1211-1216
        • Haugen B.R.
        • Alexander E.K.
        • Bible K.C.
        • et al.
        2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the american thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer.
        Thyroid. 2016; 26: 1-133
        • Kuna S.K.
        • Bracic I.
        • Tesic V.
        • et al.
        Ultrasonographic differentiation of benign from malignant neck lymphadenopathy in thyroid cancer.
        J Ultrasound Med. 2006; 25 (quiz 1538-40): 1531-1537
        • Rosário P.W.S.
        • de Faria S.
        • Bicalho L.
        • et al.
        Ultrasonographic differentiation between metastatic and benign lymph nodes in patients with papillary thyroid carcinoma.
        J Ultrasound Med. 2005; 24: 1385-1389
        • Jiang L.
        • Lee C.Y.
        • Sloan D.A.
        • et al.
        Variation in the quality of thyroid nodule evaluations before surgical referral.
        J Surg Res. 2019; 244: 9-14
        • Zhao H.
        • Li H.
        Meta-analysis of ultrasound for cervical lymph nodes in papillary thyroid cancer: diagnosis of central and lateral compartment nodal metastases.
        Eur J Radiol. 2019; 112: 14-21
        • Lee C.Y.
        • Snyder S.K.
        • Lairmore T.C.
        • et al.
        Utility of surgeon-performed ultrasound assessment of the lateral neck for metastatic papillary thyroid cancer.
        J Oncol. 2012; 2012: 973124
        • Choi J.S.
        • Kim J.
        • Kwak J.Y.
        • et al.
        Preoperative staging of papillary thyroid carcinoma: comparison of ultrasound imaging and CT.
        AJR Am J Roentgenol. 2009; 193: 871-878
        • Lesnik D.
        • Cunnane M.E.
        • Zurakowski D.
        • et al.
        Papillary thyroid carcinoma nodal surgery directed by a preoperative radiographic map utilizing CT scan and ultrasound in all primary and reoperative patients.
        Head Neck. 2014; 36: 191-202
        • Stack B.C.
        • Ferris R.L.
        • Goldenberg D.
        • et al.
        American Thyroid Association consensus review and statement regarding the anatomy, terminology, and rationale for lateral neck dissection in differentiated thyroid cancer.
        Thyroid. 2012; 22: 501-508
        • Kahramangil B.
        • Kose E.
        • Donmez M.
        • et al.
        Thyroglobulin washout from cervical lymph node fine needle aspiration biopsies in patients with differentiated thyroid cancer: an analysis of different expressions to use in post-total thyroidectomy follow-up.
        Surgery. 2020; 167: 34-39
        • Park J.H.
        • Lee Y.S.
        • Kim B.W.
        • et al.
        Skip lateral neck node metastases in papillary thyroid carcinoma.
        World J Surg. 2012; 36: 743-747
      2. Tuttle M, Morris LF, Haugen B, et al. Thyroid-differentiated and anaplastic carcinoma (Chapter 73). In: Amin MB, Edge SB, Greene F, et al. AJCC Cancer Staging Manual, 8th edition. New York: Springer International Publishing; 2017.

        • Gambardella C.
        • Tartaglia E.
        • Nunziata A.
        • et al.
        Clinical significance of prophylactic central compartment neck dissection in the treatment of clinically node-negative papillary thyroid cancer patients.
        World J Surg Oncol. 2016; 14: 247
        • Calò P.G.
        • Pisano G.
        • Medas F.
        • et al.
        Total thyroidectomy without prophylactic central neck dissection in clinically node-negative papillary thyroid cancer: is it an adequate treatment?.
        World J Surg Oncol. 2014; 12: 152
        • Gan T.
        • Huang B.
        • Chen Q.
        • et al.
        Risk of recurrence in differentiated thyroid cancer: a population-based comparison of the 7th and 8th editions of the American joint committee on cancer staging systems.
        Ann Surg Oncol. 2019; 26: 2703-2710
        • Sippel R.S.
        • Robbins S.E.
        • Poehls J.L.
        • et al.
        A randomized controlled clinical trial no clear benefit to prophylactic central neck dissection in patients with clinically node negative papillary thyroid cancer.
        Ann Surg. 2020; 272: 496-503
        • Wells S.A.
        • Asa S.L.
        • Dralle H.
        • et al.
        Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.
        Thyroid. 2015; 25: 567-610
        • Hughes D.T.
        • Laird A.M.
        • Miller B.S.
        • et al.
        Reoperative lymph node dissection for recurrent papillary thyroid cancer and effect on serum thyroglobulin.
        Ann Surg Oncol. 2012; 19: 2951-2957
        • Clayman G.L.
        • Agarwal G.
        • Edeiken B.S.
        • et al.
        Long-term outcome of comprehensive central compartment dissection in patients with recurrent/persistent papillary thyroid carcinoma.
        Thyroid. 2011; 21: 1309-1316
        • Tufano R.P.
        • Bishop J.
        • Wu G.
        Reoperative central compartment dissection for patients with recurrent/persistent papillary thyroid cancer: efficacy, safety, and the association of the BRAF mutation.
        Laryngoscope. 2012; 122: 1634-1640
        • Giordano D.
        • Valcavi R.
        • Thompson G.B.
        • et al.
        Complications of central neck dissection in patients with papillary thyroid carcinoma: results of a study on 1087 patients and review of the literature.
        Thyroid. 2012; 22: 911-917
        • Fan C.
        • Zhou X.
        • Su G.
        • et al.
        Risk factors for neck hematoma requiring surgical re-intervention after thyroidectomy: a systematic review and meta-analysis.
        BMC Surg. 2019; 19: 98
        • Chéreau N.
        • Buffet C.
        • Trésallet C.
        • et al.
        Recurrence of papillary thyroid carcinoma with lateral cervical node metastases: predictive factors and operative management.
        Surgery. 2016; 159: 755-762
        • Barczyński M.
        • Konturek A.
        • Stopa M.
        • et al.
        Nodal recurrence in the lateral neck after total thyroidectomy with prophylactic central neck dissection for papillary thyroid cancer.
        Langenbecks Arch Surg. 2014; 399: 237-244
        • Ryu I.S.
        • Song C.I.
        • Choi S.-H.
        • et al.
        Lymph node ratio of the central compartment is a significant predictor for locoregional recurrence after prophylactic central neck dissection in patients with thyroid papillary carcinoma.
        Ann Surg Oncol. 2014; 21: 277-283
        • Lee H.S.
        • Roh J.-L.
        • Gong G.
        • et al.
        Risk factors for re-recurrence after first reoperative surgery for locoregional recurrent/persistent papillary thyroid carcinoma.
        World J Surg. 2015; 39: 1943-1950
        • Yim J.H.
        • Kim W.B.
        • Kim E.Y.
        • et al.
        The outcomes of first reoperation for locoregionally recurrent/persistent papillary thyroid carcinoma in patients who initially underwent total thyroidectomy and remnant ablation.
        J Clin Endocrinol Metab. 2011; 96: 2049-2056
        • Machens A.
        • Dralle H.
        Surgical cure rates of sporadic medullary thyroid cancer in the era of calcitonin screening.
        Eur J Endocrinol. 2016; 175: 219-228
        • Miyauchi A.
        • Matsuzuka F.
        • Hirai K.
        • et al.
        Prospective trial of unilateral surgery for nonhereditary medullary thyroid carcinoma in patients without germline RET mutations.
        World J Surg. 2002; 26: 1023-1028
        • Liu F.-H.
        • Kuo S.-F.
        • Hsueh C.
        • et al.
        Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
        J Surg Oncol. 2015; 112: 149-154
        • Medas F.
        • Canu G.L.
        • Boi F.
        • et al.
        Predictive factors of recurrence in patients with differentiated thyroid carcinoma: a retrospective analysis on 579 patients.
        Cancers (Basel). 2019; 11: 1230
        • Hughes D.T.
        • Miller B.S.
        • Cohen M.S.
        • et al.
        Outcomes of total thyroidectomy with therapeutic central and lateral neck dissection with a single dose of radioiodine in the treatment of regionally advanced papillary thyroid cancer and effects on serum thyroglobulin.
        Ann Surg Oncol. 2014; 21: 1647-1652
        • O’Neill C.J.
        • Coorough N.
        • Lee J.C.
        • et al.
        Disease outcomes and nodal recurrence in patients with papillary thyroid cancer and lateral neck nodal metastases.
        ANZ J Surg. 2014; 84: 240-244